GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Alligator Bioscience ATORX.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.01

+0.99%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 514,000

FY2016FY2025

Net income

−SEK 51.4m

FY2016FY2025

Free cash flow

−SEK 157.4m

FY2016FY2025

Shareholders' equity

SEK 6.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 514,000SEK 57.8mSEK 58.1mSEK 35.7mSEK 12.9mSEK 4.4mSEK 4.4mSEK 27.0mSEK 56.9mSEK 58.2m
Research and developmentSEK 93.5mSEK 153.1mSEK 203.4mSEK 134.9mSEK 110.1mSEK 69.1mSEK 132.0mSEK 102.9mSEK 60.3mSEK 39.8m
Operating income−SEK 122.2m−SEK 229.1m−SEK 249.0m−SEK 192.8m−SEK 141.5m−SEK 144.3m−SEK 214.5m−SEK 153.1m−SEK 62.3m−SEK 56.1m
Net income−SEK 51.4m−SEK 233.9m−SEK 248.6m−SEK 193.4m−SEK 141.7m−SEK 143.6m−SEK 210.5m−SEK 150.0m−SEK 63.8m−SEK 48.4m
Diluted earnings per share-1.17-26.09-37.78-29.23-21.40-25.15-36.86-26.27-11.16-9.58

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 110.6mSEK 104.3mSEK 118.5mSEK 169.6mSEK 333.2mSEK 151.9mSEK 311.1mSEK 508.2mSEK 643.0mSEK 700.8m
Cash and short-term investmentsSEK 62.2mSEK 64.3mSEK 66.1mSEK 97.3mSEK 278.1mSEK 103.3mSEK 196.9mSEK 383.1mSEK 472.9mSEK 659.1m
Total liabilitiesSEK 103.7mSEK 234.9mSEK 106.6mSEK 80.5mSEK 50.9mSEK 36.7mSEK 52.6mSEK 39.8mSEK 25.1mSEK 24.6m
DebtSEK 43.2mSEK 43.6mSEK 16.1mSEK 24.5mSEK 9.7mSEK 12.1mSEK 17.1m−SEK 216,000——
Shareholders' equitySEK 6.9m−SEK 130.6mSEK 11.9mSEK 89.1mSEK 282.3mSEK 115.2mSEK 258.5mSEK 468.3mSEK 618.0mSEK 676.2m
Shares outstanding44m9m7m7m7m6m6m6m6m5m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 156.0m−SEK 212.4m−SEK 189.3m−SEK 172.6m−SEK 127.0m−SEK 141.4m−SEK 179.0m−SEK 104.1m−SEK 99.6m−SEK 37.6m
Capital spending−SEK 1.5m—−SEK 2.5m−SEK 440,000−SEK 45,000−SEK 102,000−SEK 2.2m−SEK 7.7m−SEK 14.2m−SEK 3.6m
Free cash flow−SEK 157.4m−SEK 212.4m−SEK 191.7m−SEK 173.0m−SEK 127.1m−SEK 141.5m−SEK 181.1m−SEK 111.8m−SEK 113.8m−SEK 41.2m
Dividends paid———−SEK 7.9m——————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-75.7%-34.8%-46.9%
Operating income-14.1%-3.3%—
Net income-35.7%-18.6%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-602.9%-521.5%-637.0%-224.9%
Net margin-489.4%-478.2%-597.8%-211.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-0.1-0.0-0.0-0.0-0.0-0.0-0.0-0.1-0.2-0.4
Price to sales4.70.00.00.00.21.11.50.50.30.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1000-to-1 reverse split · 7 Apr 2025

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.